Diagnosis and molecular monitoring of acute promyelocytic leukemia using DzyNA reverse transcription-PCR to quantify PML/RARα fusion transcripts

Clinical Chemistry

Volumn 48, Issue 8, 2002, Pages 1338-1343

  Applegate, Tanya L ^a   Iland, Harry J ^a   Mokany, Elisa ^a   Todd, Alison V ^a  

^a Australian Technology Park   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; MESSENGER RNA; PML RETINOIC ACID RECEPTOR ALPHA FUSION PROTEIN; RETINOIC ACID RECEPTOR ALPHA; RNA; UNCLASSIFIED DRUG;

ARTICLE; CALIBRATION; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC KIT; DILUTION; DISEASE COURSE; DISEASE MARKER; FLUORESCENCE; HUMAN; HUMAN CELL; MINIMAL RESIDUAL DISEASE; PATIENT MONITORING; PROMYELOCYTIC LEUKEMIA; QUANTITATIVE DIAGNOSIS; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TRANSCRIPTION REGULATION;

EID: 0036329143     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.8.1338     Document Type: Article

References (17)

1. The theory of APL
2. Transcriptional regulation in acute promyelocytic leukemia
3. All trans retinoic acid in acute promyelocytic leukemia
4. Therapy of molecular relapse in acute promyelocytic leukemia
5. Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia
6. Monitoring minimal residual disease and predicting relapse in APL by quantitating PML/RARα transcripts with a sensitive competitive RT-PCR method
7. Pre-clinical validation of a novel, highly sensitive assay to detect PML-RARα mRNA using real-time reverse-transcription polymerase chain reaction
8. A general purpose RNA-cleaving DNA enzyme
9. DzyNA-PCR: Use of DNAzymes to detect and quantify nucleic acid sequences in a real-time fluorescent format
10. Factors that influence deoxyribozyme cleavage during polymerase chain reaction
11. Factors influencing the detection of mutant K-ras in the serum of patients with colorectal cancer
12. Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR
13. Quantify gene expression using molecular beacons
14. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization
15. Molecular beacons: Probes that fluoresce upon hybridization
16. Pulsed ATRA as single therapy restores long-term remission in PML-RARα-positive acute promyelocytic leukemia patients: Real time quantification of minimal residual disease. A pilot study
17. Current recommendations for positive controls in RT-PCR assays